Welcome to the second issue of our European Life Sciences Review that covers some of the most critical developments in the pharmaceutical and medical technology sectors in the last month and is produced by our life sciences lawyers in London, Frankfurt, and Paris.
In this issue, we cover updates relating to:
Read the third issue of the
European Life Sciences Review >>